Related Experiment Video
Updated: Jun 27, 2026
08:40
Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis
Published on: February 28, 2021
Subtraction MR images in a multiple sclerosis multicenter clinical trial setting
Bastiaan Moraal1, Dominik S Meier, Peter A Poppe
1Departments of Radiology, MS Center Amsterdam, VU University Medical Center, Amsterdam, the Netherlands.
Radiology
|November 28, 2008
Summary
Subtraction magnetic resonance (MR) imaging significantly improves the detection of active multiple sclerosis (MS) lesions and treatment effects in clinical trials. This method offers greater accuracy and interobserver agreement compared to conventional MR image comparisons.
Area of Science:
- Neuroimaging
- Radiology
- Clinical Trials
Background:
- Multiple sclerosis (MS) lesion detection and quantification are crucial for monitoring disease progression and treatment efficacy.
- Conventional magnetic resonance (MR) imaging methods for assessing MS lesions can be limited by registration inaccuracies and sensitivity.
- There is a need for improved MR imaging techniques to accurately detect active MS lesions and treatment effects in multicenter trials.
Purpose of the Study:
- To evaluate the effectiveness of subtraction MR imaging in detecting active MS lesions.
- To assess the ability of subtraction MR imaging to directly quantify lesion load changes.
- To determine if subtraction MR imaging can better distinguish treatment effects in a placebo-controlled MS clinical trial compared to conventional methods.
Main Methods:
- Analysis of 46 MR study pairs from 40 patients in a multicenter clinical trial.
- Comparison of active MS lesion detection and quantification using subtraction MR images versus conventional nonregistered image pairs.
- Statistical evaluation including Wilcoxon signed rank test, intraclass correlation coefficient (ICC), and Mann-Whitney U test.
Main Results:
- Subtraction MR imaging increased active lesion detection by 1.7-fold compared to native image pairs.
- Significantly improved interobserver agreement (ICC = 0.98 vs 0.91) was observed with subtraction imaging.
- Subtraction imaging provided sufficient power to distinguish treatment arms (P = .012), unlike standard lesion load change measurements (P = .455).
Conclusions:
- MR image subtraction enhances the detection of active MS lesions with superior interobserver agreement.
- Subtraction MR imaging demonstrates increased power to differentiate treatment arms in MS clinical trials.
- This technique offers a more sensitive approach for evaluating disease activity and treatment response in multiple sclerosis.
